The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.
Open accessAbstract
Plasminogen activator-inhibitor C-1 (PAI-1) plays a critical role in the regulation of fibrinolysis, serving as the primary inhibitor of tissue-type plasminogen activator. Elevated levels of PAI-1 are a risk factor for recurrent myocardial infarction, and locally increased PAI-1 expression has been described in atherosclerotic human arteries. Recent studies have shown that the administration of angiotensin converting enzyme inhibitors reduces the risk of recurrent myocardial infarction in selected patients. Since angiotensin II (Ang II) has been reported to induce PAI-1 production in cultured astrocytes, we have hypothesized that one mechanism that may contribute to the beneficial effect of angiotensin converting enzyme inhibitors is an effect on fibrinolytic balance. In the present study, we examined the interaction of Ang II with cultured bovine aortic endothelial cells (BAECs) and the effects of this peptide on the production of PAI-1. 125I-Ang II was found to bind to BAECs in a saturable and specific manner, with an apparent Kd of 1.4 nM and Bmax of 74 fmol per mg of protein. Exposure of BAECs to Ang II induced dose-dependent increases in PAI-1 antigen in the media and in PAI-1 mRNA levels. Induction of PAI-1 mRNA expression by Ang II was not inhibited by pretreating BAECs with either Dup 753 or [Sar1, Ile8]-Ang II, agents that are known to compete effectively for binding to the two major angiotensin receptor subtypes. These data indicate that Ang II regulates the expression of PAI-1 in cultured endothelial cells and that this response is mediated via a pharmacologically distinct form of the angiotensin receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.-P., Arveiler, D., Luc, G., Bard, J.-M., Bara, L., Ricard, S., et al. (1992) · Nature · doi:10.1038/359641a0 · Cited by 1,913
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., Faire, U., Dahlén, G., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
Hamsten, A., Wiman, B., de Faire, U., & Blombäck, M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132501 · Cited by 1,342
White, B. A., & Bancroft, F. C. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34158-9 · Cited by 1,288
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
Murphy, T. J., Alexander, R. W., Griendling, K. K., Runge, M. S., & Bernstein, K. E. (1991) · Nature · doi:10.1038/351233a0 · Cited by 1,252
Plasminogen activator inhibitors
Sprengers, E., & Kluft, C. (1987) · Blood · doi:10.1182/blood.v69.2.381.381 · Cited by 1,009
Sasaki, K., Yamano, Y., Bardhan, S., Iwai, N., Murray, J. J., Hasegawa, M., Matsudat, Y., & lnagami, T. (1991) · Nature · doi:10.1038/351230a0 · Cited by 811
Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H., Pratt, R. E., & Dzau, V. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74498-6 · Cited by 768
Kambayashi, Y., Bardhan, S., Takahashi, K., Tsuzuki, S., Inui, H., Hamakubo, T., & Inagami, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74499-8 · Cited by 714
Yusuf, S., Pepine, C. J., Garces, C., Pouleur, H., Rousseau, M., Salem, D., Kostis, J., Benedict, C., Bourassa, M., & Pitt, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)92889-n · Cited by 666
Angiotensin-Converting Enzyme: Vascular Endothelial Localization
Caldwell, P. R. B., Seegal, B. C., Hsu, K. C., Das, M., & Soffer, R. L. (1976) · Science · doi:10.1126/science.175444 · Cited by 635
Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.
Schneiderman, J., Sawdey, M. S., Keeton, M. R., Bordin, G. M., Bernstein, E. F., Dilley, R. B., & Loskutoff, D. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6998 · Cited by 543
Declerck, P., Alessi, M., Verstreken, M., Kruithof, E., Juhan-Vague, I., & Collen, D. (1988) · Blood · doi:10.1182/blood.v71.1.220.220 · Cited by 537
Culture of vascular endothelium.
Gimbrone, M. A. (1976) · PubMed · Cited by 526
Clottable Protein in Limulus: Its Localization and Kinetics of Its Coagulation by Endotoxin
Levin, J., & Bang, F. B. (1968) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651195 · Cited by 468
Ridker, P. M., Gaboury, C. L., Conlin, P. R., Seely, E. W., Williams, G. H., & Vaughan, D. E. (1993) · Circulation · doi:10.1161/01.cir.87.6.1969 · Cited by 400
Self-citationMolecular biology of the renin-angiotensin system.
Griendling, K. K., Murphy, T. J., & Alexander, R. W. (1993) · Circulation · doi:10.1161/01.cir.87.6.1816 · Cited by 400
Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.
Loskutoff, D. J., van Mourik, J. A., Erickson, L. A., & Lawrence, D. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.10.2956 · Cited by 399
Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.
Pannekoek, H., Veerman, H., Lambers, H., Diergaarde, P., Verweij, C. L., van Zonneveld, A. J., & van Mourik, J. A. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04532.x · Cited by 344
Etingin, O. R., Hajjar, D. P., Hajjar, K. A., Harpel, P. C., & Nachman, R. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52266-3 · Cited by 317
Kluft, C., Verheijen, J. H., Jie, A. F. H., Rijken, D. C., Preston, F. E., Sue-Ling, H. M., Jespersen, J., & Aasen, A. O. (1985) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518509155267 · Cited by 298
Angiotensin II Stimulation of Prostaglandin Production in Cultured Human Vascular Endothelium
Gimbrone, M. A., & Alexander, R. W. (1975) · Science · doi:10.1126/science.1138377 · Cited by 278
Complete Deficiency of Plasminogen-Activator Inhibitor Type 1 Due to a Frame-Shift Mutation
Fay, W. P., Shapiro, A. D., Shih, J. L., Schleef, R. R., & Ginsburg, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212103272406 · Cited by 271
Discovery of a distinct binding site for angiotensin II (3–8), a putative angiotensin IV receptor
Swanson, G. N., Hanesworth, J. M., Sardinia, M. F., Coleman, J. K. M., Wright, J. W., Hall, K. L., Miller-Wing, A. V., Stobb, J. W., Cook, V. I., Harding, E. C., et al. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90527-2 · Cited by 268
Sawdey, M., Podor, T. J., & Loskutoff, D. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81633-7 · Cited by 242
Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.
Schleef, R. R., Higgins, D. L., Pillemer, E., & Levitt, L. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114076 · Cited by 210
Rånby, M., Bergsdorf, N., Nilsson, T., Mellbring, G., Winblad, B., & Bucht, G. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.12.2160 · Cited by 192
Influence of the angiotensin system on endothelial and smooth muscle cell migration.
Bell, L. B., & Madri, J. A. (1990) · Europe PMC (PubMed Central) · Cited by 181
Tissue plasminogen activator release in vivo in response to vasoactive agents
Smith, D., Gilbert, M., & Owen, W. (1985) · Blood · doi:10.1182/blood.v66.4.835.835 · Cited by 179
Biochemistry and Pharmacology of the Renin-Angiotensin System
Johnston, C. I. (1990) · Drugs · doi:10.2165/00003495-199000391-00005 · Cited by 150
Wright, R. A., Flapan, A. D., Alberti, K. G. M. M., Ludlam, C. A., & Fox, K. A. A. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90543-6 · Cited by 139
Effects of bradykinin and angiotensin II on intracellular Ca2+ dynamics in endothelial cells
Morgan-Boyd, R., Stewart, J. M., Vavrek, R. J., et al. (1987) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1987.253.4.c588 · Cited by 131
The Angiotensin II Receptor and the Actions of Angiotensin II
Peach, M. J., & Dostal, D. E. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199016004-00007 · Cited by 125
Renin expression by vascular endothelial cells in culture.
Lilly, L. S., Pratt, R. E., Alexander, R. W., Larson, D. M., Ellison, K., Gimbrone, M. A., & Dzau, V. J. (1985) · Circulation Research · doi:10.1161/01.res.57.2.312 · Cited by 116
Ridker, P. M., Vaughan, D. E., Stampfer, M. J., Manson, J. E., Shen, C., Newcomer, L. M., Goldhaber, S. Z., & Hennekens, C. H. (1992) · Circulation · doi:10.1161/01.cir.85.5.1822 · Cited by 77
Self-citation
Cited by
Angiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
Self-citationPlasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 806
Aldosterone in Congestive Heart Failure
Weber, K. T. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000050 · Cited by 770
Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L., Kaplan, N. M., O’Connor, C. M., O’Gara, P. T., & Oparil, S. (2007) · Circulation · doi:10.1161/circulationaha.107.183885 · Cited by 757
Metadata
- Authors
- Vaughan, D. E., Lazos, S. A., & Tong, K.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-03-01
- Volume
- 95
- Issue
- 3
- Pages
- 995-1001
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2163510728
- Cited by
- 530
- References
- 40
- FWCI
- 17.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.